Loading…
Lobbying Spend
—
Filings
33
Firms Hired
1
Active Period
2016–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · first_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · first_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · first_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Source: Senate LDA